uniQure's gene therapy for Huntington's has hit the mark in a clinical trial, raising hopes of the first treatment for the devastating neurodegenerative disease. Shares in the biotech rose sharply ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback